NASDAQ : SPRY
ARS Pharmaceuticals, Inc. — Company profile
Healthcare · Biotechnology · United States
Last price 3.66 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 363.98M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Details
| Name | ARS Pharmaceuticals, Inc. |
| Sector | Healthcare |
| Industry | Biotechnology |
| Employees | 200 |
| Founded | 2015 |
| Ceo | Donn Casale |
| Country | United States |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| Isin | US82835W1080 |
| Cusip | 82835W108 |
| Cik | 1671858 |
| Sic | 2834 |
| Stock Type | Common Stock |
Key executives
| Name | Title |
|---|---|
| Donn Casale | Chief Executive Officer, President and Director |
| Justin Chakma | Chief Business Officer |
| Dr. Robert Bell Ph.D. | Co-Founder and Chief Science Officer |
| Kathleen D. Scott CPA | Chief Financial Officer |
| Brian T. Dorsey M.S. | Chief Operating Officer |
| Alexander A. Fitzpatrick Esq. | Chief Legal Officer and Secretary |
| Daniel Relovsky | Senior Vice President of Marketing |
| Lynda Harris | Vice President of Human Resources |
| Eric Karas | Chief Commercial Officer |
Contact
| Address | 11682 El Camino Real, Suite 300, San Diego, California 92130, United States |
| Phone | 858 771 9307 |
| Website | https://ars-pharma.com |